Cardiology 2 Flashcards
Metoprolol MOA?
Beta-1 specific antagonist
Bisoprolol MOA?
Beta-1 specific antagonist
Carvedilol MOA?
Nonspecific Beta-blocker + alpha-1 blocker
Which 3 beta-blockers actually have evidence of benefit in CHF?
Metoprolol, Bisoprolol, & Carvedilol
In CHF, when might Spironolactone be effective?
Only proven effective for more advanced & serious stages (class 3 & 4), where pt is SOB @ minimal exertion or @ rest
- benefit directly related to its ability to inhibit effects of aldosterone
- NOT used @ doses in which it has a diuretic effect
What do you do when a pt w/ severe CHF on Spironolactone develops gynecomastia?
Switch it to Eplerenone
Eplerenone’s role in CHF?
Same as Spironolactone – inhibits Aldosterone & has proven mortality benefit in stage 3 & 4 CHF – however doesn’t have gynecomastia effects
Digoxin’s role in CHF
- Used to control symptoms of dyspnea & will reduce the number of hospitalizations
- there is NO mortality benefit w/ Digoxin
Digoxin – Survival benefit in CHF?
NO (inotrope)
Spironolactone – Survival benefit in CHF?
YES
Eplerenone – Survival benefit in CHF?
YES
Beta-blockers – Survival benefit in CHF?
ONLY: Metoprolol, Bisoprolol, & Carvedilol
ACE-inhibitors – Survival benefit in CHF?
YES
ARBs – Survival benefit in CHF?
YES
Ca-channel blockers – Survival benefit in CHF?
NO
Milrinone – Survival benefit in CHF?
NO (no dec’d mortality in inotropes for CHF)
*MOA = PDE-3 inhibitor (dec’s cAMP brkdwn, inc’s PKA activity… this permits an increase in calcium influx into the cell. This increase in calcium influx permits increased contractility)
Furosemide – Survival benefit in CHF?
NO
- Diuretics have NO survival benefit in CHF, they just treat symptoms when EF is low
Amrinone – Survival benefit in CHF?
NO (inotrope)
Dobutamine – Survival benefit in CHF?
NO (inotrope)
Hydralazine – Survival benefit in CHF?
YES when used in combo w/ Nitrates for systolic dysfunction
2 types of CHF & how to determine which it is?
Diastolic dysfunction:
- preserved EF, sometimes even above normal
- inability of heart to “relax” & receive blood
Systolic dysfunction:
- decreased EF
- Dilation of the heart
2 non-pharm treatments ass’d w/ mortality benefit in CHF?
Implantable Defibrillator
&
Biventricular pacemaker
Implantable Defibrillator – indications?
Ischemic cardiomyopathy & EF < 35%
- 25% risk reduction in risk of death
Biventricular Pacemaker – indications?
Dilated cardiomyopathy & EF < 35% & wide QRS above 120 milliseconds w/ persistent symptoms
(note: biventricular diff from dual-chamber, which is atrium & ventricle)
Txs w/ clear mortality benefit in systolic-dysfunction CHF?
- ACEi/ARBs
- Beta-blockers
- Spironolactone or Eplerenone
- Hydralazine/Nitrates
- Implantable Defibrillator
(biventricular pacemaker..?)
Txs w/ clear mortality benefit in diastolic-dysfunction CHF?
Beta blockers & diuretics
uncertain: ACEis, ARBs, & Hydralizine
Txs clearly NOT beneficial in diastolic dysfunction CHF?
Digoxin & Spironolactone
Worst, most severe form of CHF presents w/ what?
Pulmonary Edema (rapid fluid buildup in lungs)
Dx test that can exclude pulmonary edema as cause of SOB?
BNP level — if normal, excludes both Pulmonary Edema & CHF as potential causes of the SOB